Humana Inc vs ZIM Integrated Shipping Services Ltd — how do they compare? Humana Inc trades at $444.98 (market cap $47.61B), while ZIM Integrated Shipping Services Ltd trades at $30.11 (market cap $3.61B). The key difference: Humana Inc is far larger — about 13.2× ZIM Integrated Shipping Services Ltd's market cap, and ZIM Integrated Shipping Services Ltd pays the higher dividend (20.16%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and ZIM Integrated Shipping Services Ltd for 27 Days on average.
| HUM | ZIM | |
|---|---|---|
Market Cap | $47.61B | $3.61B |
Volume | 1,827,332 | 1,800,267 |
Sector | Health | Industrials |
52-Week High | $409.85 | $30.51 |
52-Week Low | $163.67 | $12.44 |
Typical Hold Time | 53 Days | 27 Days |
Enterprise Value | $54.97B | $7.29B |
Dividend Yield | 0.89% | 20.16% |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
ZIM trades at $29.99, up 2.71% today, near its 52-week high of $30.96. The stock shows a bullish technical trend with strong moving average signals. Fundamentally, Q2 2026 earnings beat estimates with $0.53 EPS versus a $0.02 loss expected, driven by higher freight rates and volumes. Revenue for 2025 was $6.9B with a net income of $479M, though 2026 projections show lower profitability. Recent news highlights a potential acquisition offer from Hapag-Lloyd at $35 per share, pending Israeli government approval.
The outlook is mixed: upside is capped by merger uncertainty and declining 2026 profit margins, but the acquisition premium offers potential gains. Risks include regulatory hurdles for the deal and volatile shipping rates. Analyst sentiment is cautious with no buy ratings, reflecting concerns over execution and external pressures. Investors should weigh the acquisition possibility against fundamental erosion.
Trailing returns across standard periods
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →ZIM is a global container liner shipping company that employs a 'global-niche' strategy, focusing on specific trade lanes where it holds a competitive advantage. Unlike larger, asset-heavy competitors, ZIM operates an agile, charter-intensive fleet, allowing it to rapidly adjust capacity to market demand while prioritizing digitalization and specialized cargo like refrigerated (reefer) goods.
Read more on ZIM →